(Q33712928)

28 July 2017

A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment (English)

1 reference

28 July 2017

1 reference

2

Christoph Engel

1 reference

28 July 2017

Sibylle Schirm

1

1 reference

28 July 2017

Markus Loeffler

series ordinal

3

1 reference

28 July 2017

Markus Scholz

series ordinal

4

1 reference

28 July 2017

26 May 2014

1 reference

Theoretical Biology and Medical Modelling

28 July 2017

1 reference

28 July 2017

11

1 reference

28 July 2017

24

1 reference

https://scigraph.springernature.com/pub.10.1186/1742-4682-11-24

28 July 2017

0 references

cites work

Merging concepts - coupling an agent-based model of hematopoietic stem cells with an ODE model of granulopoiesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Does model-free forecasting really outperform the true model?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Model-free forecasting outperforms the correct mechanistic model for simulated and experimental data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A biomathematical model of human thrombopoiesis under chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Mathematical study of feedback control roles and relevance in stress erythropoiesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

The impact of PEGylation on biological therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Pharmacology of darbepoetin alfa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Lineage specification of hematopoietic stem cells: mathematical modeling and biological implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A mathematical model of haemopoiesis as exemplified by CD34 cell mobilization into the peripheral blood

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Pharmacokinetics of pegfilgrastim

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Parsing the effects of binding, signaling, and trafficking on the mitogenic potencies of granulocyte colony-stimulating factor analogues

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Effect of pegylation on pharmaceuticals

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Clinical uses of pegylated pharmaceuticals in oncology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Novel effects with polyethylene glycol modified pharmaceuticals

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Optimizing the use of erythropoietic agents-- pharmacokinetic and pharmacodynamic considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Hematopoietic cytokines, transcription factors and lineage commitment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Interactions of erythropoietin, granulocyte colony-stimulating factor, stem cell factor, and interleukin-11 on murine hematopoiesis during simultaneous administration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A mathematical model of erythropoiesis in mice and rats. Part 1: Structure of the model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A mathematical model of erythropoiesis in mice and rats. Part 4: Differences between bone marrow and spleen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Modelling human granulopoiesis under poly-chemotherapy with G-CSF support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Cell-level pharmacokinetic model of granulocyte colony-stimulating factor: implications for ligand lifetime and potency in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primar

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Mathematical modeling of granulocyte reconstitution after high-dose chemotherapy with stem cell support: effect of post-transplant G-CSF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

G-CSF control of neutrophils dynamics in the blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Cost-effective G-CSF therapy strategies for cyclical neutropenia: mathematical modelling based hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Mathematical model for G-CSF administration after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Age-structured and two-delay models for erythropoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

G-CSF treatment of canine cyclical neutropenia: a comprehensive mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A mathematical model of hematopoiesis: II. Cyclical neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Neutrophil dynamics after chemotherapy and G-CSF: the role of pharmacokinetics in shaping the response.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

A model of erythropoiesis in adults with sufficient iron availability.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Neutrophil dynamics in response to chemotherapy and G-CSF.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Modeling and optimal regulation of erythropoiesis subject to benzene intoxication

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

PROLIFERATION OF HEMOPOIETIC COLONY-FORMING CELLS TRANSPLANTED INTO IRRADIATED MICE

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Pharmacokinetics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in healthy male volunteers

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046020

Lymphatic Absorption of Subcutaneously Administered Proteins: Influence of Different Injection Sites on the Absorption of Darbepoetin Alfa Using a Sheep Model

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-4682-11-24

Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers

1 reference

12 December 2020

Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia

1 reference

12 December 2020

Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats

1 reference

12 December 2020

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

1 reference

12 December 2020

The complex effect of granulocyte colony-stimulating factor on human granulopoiesis analyzed by a new physiologically-based mathematical model

1 reference

12 December 2020

The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis

1 reference

12 December 2020

Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats

1 reference

12 December 2020

Effects of G-CSF on erythropoiesis

1 reference

12 December 2020

Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1186/1742-4682-11-24

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference